MIODx Aims to Develop Immune Repertoire Sequencing Assay to Predict Immunotherapy Response – GenomeWeb
|
MIODx Aims to Develop Immune Repertoire Sequencing Assay to Predict Immunotherapy Response
GenomeWeb SAN FRANCISCO (GenomeWeb) – MIODx is developing immune repertoire sequencing-based tests to predict whether patients will have a favorable response to immunotherapy and whether they will have adverse immune reactions as a result of the therapy. The San … |
